Table of Contents 1 Primary Sclerosing Cholangitis Treatment Market Overview 1.1 Product Overview and Scope of Primary Sclerosing Cholangitis Treatment 1.2 Classification of Primary Sclerosing Cholangitis Treatment by Types 1.2.1 Global Primary Sclerosing Cholangitis Treatment Revenue Comparison by Types (2019-2024) 1.2.2 Global Primary Sclerosing Cholangitis Treatment Revenue Market Share by Types in 2018 1.2.3 Liver Transplantation Operation 1.2.4 UDCA Drugs 1.2.5 PSC Drugs 1.3 Global Primary Sclerosing Cholangitis Treatment Market by Application 1.3.1 Global Primary Sclerosing Cholangitis Treatment Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Other 1.4 Global Primary Sclerosing Cholangitis Treatment Market by Regions 1.4.1 Global Primary Sclerosing Cholangitis Treatment Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Primary Sclerosing Cholangitis Treatment Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Primary Sclerosing Cholangitis Treatment Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Primary Sclerosing Cholangitis Treatment Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Primary Sclerosing Cholangitis Treatment Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Primary Sclerosing Cholangitis Treatment Status and Prospect (2014-2024) 1.5 Global Market Size of Primary Sclerosing Cholangitis Treatment (2014-2024) 2 Company Profiles 2.1 Allergan 2.1.1 Business Overview 2.1.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Allergan Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.2 Epic Pharma 2.2.1 Business Overview 2.2.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Epic Pharma Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.3 Mylan 2.3.1 Business Overview 2.3.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Mylan Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.4 Glenmark 2.4.1 Business Overview 2.4.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Glenmark Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.5 Daewoong Pharmaceutical 2.5.1 Business Overview 2.5.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Daewoong Pharmaceutical Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.6 Impax Laboratories 2.6.1 Business Overview 2.6.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Impax Laboratories Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.7 Lannett 2.7.1 Business Overview 2.7.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Lannett Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.8 Dr. Falk Pharma 2.8.1 Business Overview 2.8.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Dr. Falk Pharma Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.9 Teva Pharmaceuticals 2.9.1 Business Overview 2.9.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Teva Pharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.10 Mitsubishi Tanabe Pharma 2.10.1 Business Overview 2.10.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Mitsubishi Tanabe Pharma Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.11 Gilead Sciences 2.11.1 Business Overview 2.11.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Gilead Sciences Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.12 NGM Biopharmaceuticals 2.12.1 Business Overview 2.12.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 NGM Biopharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.13 Bruschettini 2.13.1 Business Overview 2.13.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Bruschettini Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.14 Durect Corporation 2.14.1 Business Overview 2.14.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 Durect Corporation Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.15 Intercept Pharmaceuticals 2.15.1 Business Overview 2.15.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Intercept Pharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.16 Acorda Therapeutics 2.16.1 Business Overview 2.16.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Acorda Therapeutics Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.17 Shanghai Pharma 2.17.1 Business Overview 2.17.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Shanghai Pharma Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.18 Conatus Pharmaceuticals 2.18.1 Business Overview 2.18.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 Conatus Pharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.19 Shire Plc 2.19.1 Business Overview 2.19.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Shire Plc Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.20 Grindeks 2.20.1 Business Overview 2.20.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.20.2.1 Product A 2.20.2.2 Product B 2.20.3 Grindeks Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.21 Sirnaomics 2.21.1 Business Overview 2.21.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.21.2.1 Product A 2.21.2.2 Product B 2.21.3 Sirnaomics Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.22 Shenzhen HighTide Biopharmaceuticals 2.22.1 Business Overview 2.22.2 Primary Sclerosing Cholangitis Treatment Type and Applications 2.22.2.1 Product A 2.22.2.2 Product B 2.22.3 Shenzhen HighTide Biopharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) 3 Global Primary Sclerosing Cholangitis Treatment Market Competition, by Players 3.1 Global Primary Sclerosing Cholangitis Treatment Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Primary Sclerosing Cholangitis Treatment Players Market Share 3.2.2 Top 10 Primary Sclerosing Cholangitis Treatment Players Market Share 3.3 Market Competition Trend 4 Global Primary Sclerosing Cholangitis Treatment Market Size by Regions 4.1 Global Primary Sclerosing Cholangitis Treatment Revenue and Market Share by Regions 4.2 North America Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 4.3 Europe Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 4.5 South America Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 5 North America Primary Sclerosing Cholangitis Treatment Revenue by Countries 5.1 North America Primary Sclerosing Cholangitis Treatment Revenue by Countries (2014-2019) 5.2 USA Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 5.3 Canada Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 5.4 Mexico Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 6 Europe Primary Sclerosing Cholangitis Treatment Revenue by Countries 6.1 Europe Primary Sclerosing Cholangitis Treatment Revenue by Countries (2014-2019) 6.2 Germany Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 6.3 UK Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 6.4 France Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 6.5 Russia Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 6.6 Italy Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue by Countries 7.1 Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue by Countries (2014-2019) 7.2 China Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 7.3 Japan Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 7.4 Korea Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 7.5 India Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 8 South America Primary Sclerosing Cholangitis Treatment Revenue by Countries 8.1 South America Primary Sclerosing Cholangitis Treatment Revenue by Countries (2014-2019) 8.2 Brazil Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 8.3 Argentina Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 8.4 Colombia Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Primary Sclerosing Cholangitis Treatment by Countries 9.1 Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue by Countries (2014-2019) 9.2 Saudi Arabia Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 9.3 UAE Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 9.4 Egypt Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 9.5 Nigeria Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 9.6 South Africa Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) 10 Global Primary Sclerosing Cholangitis Treatment Market Segment by Type 10.1 Global Primary Sclerosing Cholangitis Treatment Revenue and Market Share by Type (2014-2019) 10.2 Global Primary Sclerosing Cholangitis Treatment Market Forecast by Type (2019-2024) 10.3 Liver Transplantation Operation Revenue Growth Rate (2014-2024) 10.4 UDCA Drugs Revenue Growth Rate (2014-2024) 10.5 PSC Drugs Revenue Growth Rate (2014-2024) 11 Global Primary Sclerosing Cholangitis Treatment Market Segment by Application 11.1 Global Primary Sclerosing Cholangitis Treatment Revenue Market Share by Application (2014-2019) 11.2 Primary Sclerosing Cholangitis Treatment Market Forecast by Application (2019-2024) 11.3 Hospital Revenue Growth (2014-2019) 11.4 Clinics Revenue Growth (2014-2019) 11.5 Other Revenue Growth (2014-2019) 12 Global Primary Sclerosing Cholangitis Treatment Market Size Forecast (2019-2024) 12.1 Global Primary Sclerosing Cholangitis Treatment Market Size Forecast (2019-2024) 12.2 Global Primary Sclerosing Cholangitis Treatment Market Forecast by Regions (2019-2024) 12.3 North America Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) 12.4 Europe Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) 12.6 South America Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Primary Sclerosing Cholangitis Treatment Picture Table Product Specifications of Primary Sclerosing Cholangitis Treatment Table Global Primary Sclerosing Cholangitis Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Primary Sclerosing Cholangitis Treatment Revenue Market Share by Types in 2018 Figure Liver Transplantation Operation Picture Figure UDCA Drugs Picture Figure PSC Drugs Picture Table Global Primary Sclerosing Cholangitis Treatment Revenue (Million USD) by Application (2014-2024) Figure Primary Sclerosing Cholangitis Treatment Revenue Market Share by Applications in 2018 Figure Hospital Picture Figure Clinics Picture Figure Other Picture Table Global Market Primary Sclerosing Cholangitis Treatment Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Primary Sclerosing Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Primary Sclerosing Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Primary Sclerosing Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Primary Sclerosing Cholangitis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Table Allergan Basic Information, Manufacturing Base and Competitors Table Allergan Primary Sclerosing Cholangitis Treatment Type and Applications Table Allergan Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Epic Pharma Basic Information, Manufacturing Base and Competitors Table Epic Pharma Primary Sclerosing Cholangitis Treatment Type and Applications Table Epic Pharma Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Mylan Basic Information, Manufacturing Base and Competitors Table Mylan Primary Sclerosing Cholangitis Treatment Type and Applications Table Mylan Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Glenmark Basic Information, Manufacturing Base and Competitors Table Glenmark Primary Sclerosing Cholangitis Treatment Type and Applications Table Glenmark Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Daewoong Pharmaceutical Primary Sclerosing Cholangitis Treatment Type and Applications Table Daewoong Pharmaceutical Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Impax Laboratories Basic Information, Manufacturing Base and Competitors Table Impax Laboratories Primary Sclerosing Cholangitis Treatment Type and Applications Table Impax Laboratories Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Lannett Basic Information, Manufacturing Base and Competitors Table Lannett Primary Sclerosing Cholangitis Treatment Type and Applications Table Lannett Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Dr. Falk Pharma Basic Information, Manufacturing Base and Competitors Table Dr. Falk Pharma Primary Sclerosing Cholangitis Treatment Type and Applications Table Dr. Falk Pharma Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceuticals Primary Sclerosing Cholangitis Treatment Type and Applications Table Teva Pharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors Table Mitsubishi Tanabe Pharma Primary Sclerosing Cholangitis Treatment Type and Applications Table Mitsubishi Tanabe Pharma Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Gilead Sciences Basic Information, Manufacturing Base and Competitors Table Gilead Sciences Primary Sclerosing Cholangitis Treatment Type and Applications Table Gilead Sciences Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table NGM Biopharmaceuticals Basic Information, Manufacturing Base and Competitors Table NGM Biopharmaceuticals Primary Sclerosing Cholangitis Treatment Type and Applications Table NGM Biopharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Bruschettini Basic Information, Manufacturing Base and Competitors Table Bruschettini Primary Sclerosing Cholangitis Treatment Type and Applications Table Bruschettini Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Durect Corporation Basic Information, Manufacturing Base and Competitors Table Durect Corporation Primary Sclerosing Cholangitis Treatment Type and Applications Table Durect Corporation Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Intercept Pharmaceuticals Primary Sclerosing Cholangitis Treatment Type and Applications Table Intercept Pharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Acorda Therapeutics Basic Information, Manufacturing Base and Competitors Table Acorda Therapeutics Primary Sclerosing Cholangitis Treatment Type and Applications Table Acorda Therapeutics Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Shanghai Pharma Basic Information, Manufacturing Base and Competitors Table Shanghai Pharma Primary Sclerosing Cholangitis Treatment Type and Applications Table Shanghai Pharma Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Conatus Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Conatus Pharmaceuticals Primary Sclerosing Cholangitis Treatment Type and Applications Table Conatus Pharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Shire Plc Basic Information, Manufacturing Base and Competitors Table Shire Plc Primary Sclerosing Cholangitis Treatment Type and Applications Table Shire Plc Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Grindeks Basic Information, Manufacturing Base and Competitors Table Grindeks Primary Sclerosing Cholangitis Treatment Type and Applications Table Grindeks Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Sirnaomics Basic Information, Manufacturing Base and Competitors Table Sirnaomics Primary Sclerosing Cholangitis Treatment Type and Applications Table Sirnaomics Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Shenzhen HighTide Biopharmaceuticals Basic Information, Manufacturing Base and Competitors Table Shenzhen HighTide Biopharmaceuticals Primary Sclerosing Cholangitis Treatment Type and Applications Table Shenzhen HighTide Biopharmaceuticals Primary Sclerosing Cholangitis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Global Primary Sclerosing Cholangitis Treatment Revenue (Million USD) by Players (2014-2019) Table Global Primary Sclerosing Cholangitis Treatment Revenue Share by Players (2014-2019) Figure Global Primary Sclerosing Cholangitis Treatment Revenue Share by Players in 2017 Figure Global Primary Sclerosing Cholangitis Treatment Revenue Share by Players in 2018 Figure Global Top 5 Players Primary Sclerosing Cholangitis Treatment Revenue Market Share in 2018 Figure Global Top 10 Players Primary Sclerosing Cholangitis Treatment Revenue Market Share in 2018 Figure Global Primary Sclerosing Cholangitis Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Primary Sclerosing Cholangitis Treatment Revenue (Million USD) by Regions (2014-2019) Table Global Primary Sclerosing Cholangitis Treatment Revenue Market Share by Regions (2014-2019) Figure Global Primary Sclerosing Cholangitis Treatment Revenue Market Share by Regions (2014-2019) Figure Global Primary Sclerosing Cholangitis Treatment Revenue Market Share by Regions in 2018 Figure North America Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Europe Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure South America Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Table North America Primary Sclerosing Cholangitis Treatment Revenue by Countries (2014-2019) Table North America Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries (2014-2019) Figure North America Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries (2014-2019) Figure North America Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries in 2018 Figure USA Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Canada Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Mexico Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Table Europe Primary Sclerosing Cholangitis Treatment Revenue (Million USD) by Countries (2014-2019) Figure Europe Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries (2014-2019) Figure Europe Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries in 2018 Figure Germany Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure UK Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure France Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Russia Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Italy Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Table Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries in 2018 Figure China Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Japan Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Korea Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure India Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Southeast Asia Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Table South America Primary Sclerosing Cholangitis Treatment Revenue by Countries (2014-2019) Table South America Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries (2014-2019) Figure South America Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries (2014-2019) Figure South America Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries in 2018 Figure Brazil Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Argentina Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Colombia Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Table Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue Market Share by Countries in 2018 Figure Saudi Arabia Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure UAE Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Egypt Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure Nigeria Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Figure South Africa Primary Sclerosing Cholangitis Treatment Revenue and Growth Rate (2014-2019) Table Global Primary Sclerosing Cholangitis Treatment Revenue (Million USD) by Type (2014-2019) Table Global Primary Sclerosing Cholangitis Treatment Revenue Share by Type (2014-2019) Figure Global Primary Sclerosing Cholangitis Treatment Revenue Share by Type (2014-2019) Figure Global Primary Sclerosing Cholangitis Treatment Revenue Share by Type in 2018 Table Global Primary Sclerosing Cholangitis Treatment Revenue Forecast by Type (2019-2024) Figure Global Primary Sclerosing Cholangitis Treatment Market Share Forecast by Type (2019-2024) Figure Global Liver Transplantation Operation Revenue Growth Rate (2014-2019) Figure Global UDCA Drugs Revenue Growth Rate (2014-2019) Figure Global PSC Drugs Revenue Growth Rate (2014-2019) Table Global Primary Sclerosing Cholangitis Treatment Revenue by Application (2014-2019) Table Global Primary Sclerosing Cholangitis Treatment Revenue Share by Application (2014-2019) Figure Global Primary Sclerosing Cholangitis Treatment Revenue Share by Application (2014-2019) Figure Global Primary Sclerosing Cholangitis Treatment Revenue Share by Application in 2018 Table Global Primary Sclerosing Cholangitis Treatment Revenue Forecast by Application (2019-2024) Figure Global Primary Sclerosing Cholangitis Treatment Market Share Forecast by Application (2019-2024) Figure Global Hospital Revenue Growth Rate (2014-2019) Figure Global Clinics Revenue Growth Rate (2014-2019) Figure Global Other Revenue Growth Rate (2014-2019) Figure Global Primary Sclerosing Cholangitis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Primary Sclerosing Cholangitis Treatment Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Primary Sclerosing Cholangitis Treatment Revenue Market Share Forecast by Regions (2019-2024) Figure North America Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) Figure Europe Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) Figure Asia-Pacific Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) Figure South America Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024) Figure Middle East and Africa Primary Sclerosing Cholangitis Treatment Revenue Market Forecast (2019-2024)

Allergan Epic Pharma Mylan Glenmark Daewoong Pharmaceutical Impax Laboratories Lannett Dr. Falk Pharma Teva Pharmaceuticals Mitsubishi Tanabe Pharma Gilead Sciences NGM Biopharmaceuticals Bruschettini Durect Corporation Intercept Pharmaceuticals Acorda Therapeutics Shanghai Pharma Conatus Pharmaceuticals Shire Plc Grindeks Sirnaomics Shenzhen HighTide Biopharmaceuticals